Latest Healthcare News

Page 4 of 138
Echo IQ has strengthened its partnership with Mayo Clinic to distribute its AI-driven heart failure diagnostic tool, EchoSolv HF, pending FDA clearance. The expanded agreement offers a scalable commercial pathway across a vast US hospital network.
Ada Torres
Ada Torres
24 Mar 2026
Cyclopharm has secured a multi-site agreement with Northwestern Medicine, marking a major expansion into Chicago’s healthcare market and reinforcing its US growth strategy.
Ada Torres
Ada Torres
24 Mar 2026
BlinkLab’s smartphone-based Dx1 autism screening technology has been selected for Morocco’s government-funded national early screening program, marking a major milestone in digital health adoption and autism care.
Ada Torres
Ada Torres
23 Mar 2026
Terra Critical Minerals has expanded its footprint in New South Wales with a new exploration license at the historic Silent Grove tin project, revealing significant historical tin mineralisation up to 5.21%. The company plans modern exploration to unlock this critical mineral’s potential amid rising global demand.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.
Ada Torres
Ada Torres
23 Mar 2026
Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.
Ada Torres
Ada Torres
23 Mar 2026
Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.
Ada Torres
Ada Torres
23 Mar 2026
Enlitic has secured a $1.5 million contract to migrate over 71 million clinical files for Penn Medicine Doylestown Health, reinforcing its foothold in the US healthcare IT sector.
Ada Torres
Ada Torres
23 Mar 2026
Synlait confirms the imminent sale of its North Island assets to Abbott for NZ$307 million, aiming to reset its balance sheet amid a challenging half-year result. The company unveils a recovery roadmap focused on stabilising and scaling its core operations.
Victor Sage
Victor Sage
23 Mar 2026
Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.
Ada Torres
Ada Torres
20 Mar 2026
Recce Pharmaceuticals is progressing its Phase 3 clinical trial of RECCE 327, a novel synthetic antibiotic targeting multidrug-resistant infections, with interim data from Indonesia supporting registration plans across ASEAN by 2026.
Ada Torres
Ada Torres
19 Mar 2026
Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.
Ada Torres
Ada Torres
19 Mar 2026